JPS6142531A - 微孔性の粉末状ポリラクチドの製法 - Google Patents
微孔性の粉末状ポリラクチドの製法Info
- Publication number
- JPS6142531A JPS6142531A JP60169942A JP16994285A JPS6142531A JP S6142531 A JPS6142531 A JP S6142531A JP 60169942 A JP60169942 A JP 60169942A JP 16994285 A JP16994285 A JP 16994285A JP S6142531 A JPS6142531 A JP S6142531A
- Authority
- JP
- Japan
- Prior art keywords
- polylactide
- powder
- microporous
- acid
- lactic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000747 poly(lactic acid) Polymers 0.000 title claims description 53
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 239000000843 powder Substances 0.000 claims description 39
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 claims description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 6
- 229920001577 copolymer Polymers 0.000 claims description 5
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- 238000000967 suction filtration Methods 0.000 claims description 2
- 229960000448 lactic acid Drugs 0.000 claims 2
- 239000013543 active substance Substances 0.000 description 30
- 239000000243 solution Substances 0.000 description 16
- 239000003814 drug Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000001816 cooling Methods 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000009969 flowable effect Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- VGUWZCUCNQXGBU-UHFFFAOYSA-N 3-[(4-methylpiperazin-1-yl)methyl]-5-nitro-1h-indole Chemical compound C1CN(C)CCN1CC1=CNC2=CC=C([N+]([O-])=O)C=C12 VGUWZCUCNQXGBU-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229920006237 degradable polymer Polymers 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- -1 diethyl phthalate ester Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 239000011796 hollow space material Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012229 microporous material Substances 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
- C08J3/14—Powdering or granulating by precipitation from solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
- C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
- C08G63/08—Lactones or lactides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2367/00—Characterised by the use of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Derivatives of such polymers
- C08J2367/04—Polyesters derived from hydroxy carboxylic acids, e.g. lactones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Polyesters Or Polycarbonates (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3428640A DE3428640A1 (de) | 1984-08-03 | 1984-08-03 | Mikroporoese, pulverfoermige polylactide |
| DE3428640.3 | 1984-08-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6142531A true JPS6142531A (ja) | 1986-03-01 |
| JPH0523288B2 JPH0523288B2 (en, 2012) | 1993-04-02 |
Family
ID=6242270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60169942A Granted JPS6142531A (ja) | 1984-08-03 | 1985-08-02 | 微孔性の粉末状ポリラクチドの製法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US4645664A (en, 2012) |
| EP (1) | EP0171603B1 (en, 2012) |
| JP (1) | JPS6142531A (en, 2012) |
| DE (2) | DE3428640A1 (en, 2012) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5646238A (en) * | 1994-07-27 | 1997-07-08 | Mitsui Toatsu Chemicals, Inc. | Preparation process of polyhydroxycarboxylic acid |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5250584A (en) * | 1988-08-31 | 1993-10-05 | G-C Dental Industrial Corp. | Periodontium-regenerative materials |
| ZW17589A1 (en) * | 1988-12-23 | 1990-08-01 | Ici Plc | Non-attritive method for making polyester,polycarbonate or polyamide particles,particles obtainable by the method and their use |
| US5223546A (en) * | 1991-04-24 | 1993-06-29 | Mitsui Toatsu Chemicals, Inc. | High polymer network |
| WO1993015722A1 (en) * | 1992-02-07 | 1993-08-19 | Syntex (Usa) Inc. | Controlled delivery of pharmaceuticals from preformed porous microparticles |
| US5518730A (en) | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
| DE4234620A1 (de) * | 1992-10-14 | 1994-04-21 | Basf Ag | Verfahren zur Herstellung von geschäumten Polylactid Spritzgießteilen hoher Festigkeit und Steifigkeit |
| US6090925A (en) | 1993-03-09 | 2000-07-18 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
| US5569468A (en) * | 1994-02-17 | 1996-10-29 | Modi; Pankaj | Vaccine delivery system for immunization, using biodegradable polymer microspheres |
| US5417982A (en) * | 1994-02-17 | 1995-05-23 | Modi; Pankaj | Controlled release of drugs or hormones in biodegradable polymer microspheres |
| WO2002067993A1 (fr) * | 2001-02-27 | 2002-09-06 | Senju Pharmaceutical Co., Ltd. | Systeme de liberation de medicament de type polymere biodegradable |
| US7198844B2 (en) * | 2003-01-17 | 2007-04-03 | Crompton Corporation | Microporous polymeric resin containing stabilizers and method for making thereof |
| EP2402390A1 (en) | 2010-06-30 | 2012-01-04 | Basf Se | Particles with a hindered amine light stabilizer and a microporous organic polymer |
| JP7069137B2 (ja) | 2016-10-07 | 2022-05-17 | ビーエーエスエフ ソシエタス・ヨーロピア | 球状微粒子 |
| EP3774015A1 (de) | 2018-04-06 | 2021-02-17 | Basf Se | Sphärische mikropartikel |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1871725A (en) * | 1928-10-20 | 1932-08-16 | Celanese Corp | Laminated glass and method of making same |
| US3498957A (en) * | 1965-09-14 | 1970-03-03 | Ethicon Inc | Polymerization of cyclic carboxylic esters in the presense of a nonpolymerizable ester plasticizer |
| US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4247498A (en) * | 1976-08-30 | 1981-01-27 | Akzona Incorporated | Methods for making microporous products |
| US4137921A (en) * | 1977-06-24 | 1979-02-06 | Ethicon, Inc. | Addition copolymers of lactide and glycolide and method of preparation |
| US4273920A (en) * | 1979-09-12 | 1981-06-16 | Eli Lilly And Company | Polymerization process and product |
| AU539230B2 (en) * | 1979-09-12 | 1984-09-20 | Eli Lilly And Company | Parasitic formulations and method |
| DE3218150C2 (de) * | 1982-05-14 | 1986-09-25 | Akzo Gmbh, 5600 Wuppertal | Wirkstoff enthaltender Körper für die Langzeitabgabe sowie Verfahren zu dessen Herstellung |
| DE3218151A1 (de) * | 1982-05-14 | 1983-11-17 | Akzo Gmbh, 5600 Wuppertal | Mikroporoese, pulverfoermige polylactide und verfahren zu deren herstellung |
| CA1196864A (en) * | 1983-06-10 | 1985-11-19 | Mattheus F.A. Goosen | Controlled release of injectable and implantable insulin compositions |
-
1984
- 1984-08-03 DE DE3428640A patent/DE3428640A1/de active Granted
-
1985
- 1985-07-10 EP EP85108582A patent/EP0171603B1/de not_active Expired
- 1985-07-10 DE DE8585108582T patent/DE3567892D1/de not_active Expired
- 1985-07-31 US US06/761,106 patent/US4645664A/en not_active Expired - Fee Related
- 1985-08-02 JP JP60169942A patent/JPS6142531A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5646238A (en) * | 1994-07-27 | 1997-07-08 | Mitsui Toatsu Chemicals, Inc. | Preparation process of polyhydroxycarboxylic acid |
Also Published As
| Publication number | Publication date |
|---|---|
| DE3428640C2 (en, 2012) | 1988-12-15 |
| US4645664A (en) | 1987-02-24 |
| EP0171603B1 (de) | 1989-01-25 |
| DE3428640A1 (de) | 1986-02-06 |
| DE3567892D1 (en) | 1989-03-02 |
| EP0171603A1 (de) | 1986-02-19 |
| JPH0523288B2 (en, 2012) | 1993-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6142531A (ja) | 微孔性の粉末状ポリラクチドの製法 | |
| DE69420632T2 (de) | Verfahren zur Herstellung von Arzneizubereitungen mit verzögerter Wirkstoffabgabe | |
| JP4942914B2 (ja) | 内部的に分散沈殿物を有する高分子複合材料 | |
| DE3200763C2 (en, 2012) | ||
| US4471077A (en) | Microporous polylactide powders and a process for their preparation | |
| DE3542972A1 (de) | Pharmakadepot | |
| JPS61277629A (ja) | 巨大分子薬物の制御された放出送達システム | |
| JP3834331B2 (ja) | 表面活性剤を含有しない生体再吸収性重合体微小球、その製造及び薬剤としてその応用 | |
| JPS59500417A (ja) | 車前子組成物 | |
| KR20030051687A (ko) | 분자량이 감소된 정제 아밀로펙틴-기제 녹말을 갖는서방투여용 생분해성 미세입자 | |
| CN1546557A (zh) | 羧甲基壳聚糖和海藻酸钠共混微胶囊的制备方法及用途 | |
| US3039933A (en) | Ethyl cellulose-polyethylene glycol tablet matrix | |
| JPS58208212A (ja) | 作用物質を長時間放出するための作用物質を含有する支持体及びその製造法 | |
| US4761289A (en) | Sustained release implant and method for preparing same | |
| TW477802B (en) | Method for preparing hydrophilic porous polymeric materials | |
| CN109439645B (zh) | 利用锐孔法制备解磷微生物缓释海藻酸钠微球的方法 | |
| US4379038A (en) | Process for preparing a physiologically active substance controlled release composite composition | |
| CN1903383B (zh) | 生物吸收性颗粒状多孔骨填充材料的制备方法 | |
| JPS6163613A (ja) | 顆粒状に調整された徐放性製剤 | |
| JPH05262671A (ja) | 医薬品コーティング液用原料粉粒体 | |
| JPH072652A (ja) | 乾式加工された粒子の製造方法、該方法で製造された乾式加工された粒子及び該粒子を含有する医薬組成物 | |
| JPH04217914A (ja) | 徐放性製剤の製造方法 | |
| JP2014218464A (ja) | 均一分散可能な架橋ゼラチン粒子集合体 | |
| RU2753343C2 (ru) | Способ получения порошка β-полугидрата сульфата кальция | |
| US3920806A (en) | Growth promoting subcutaneous compositions |